Claire Dooley warned that biotech’s embrace of genetic engineering is being sold as compassion, yet the industry still profits from sickness and is pushing deeper into genome sequencing, designer babies, and AI driven health control.
Watch the clip below.
This clip aired on WarRoom’s morning show on November 13, 2025. Transcript begins below (lightly edited for clarity; may contain minor errors).
STEVE BANNON (HOST): Claire Dooley, thank you for doing this, and we’re going to have you back tomorrow. You’re doing some analytics on what’s happening. Our audience is so focused on being part of Make America Healthy Again. You had a huge conference yesterday, a group of all stars. Tony Lyons and his team were over there. Just walk us through briefly, because I know you’re doing a write up about it, but I wanted to get people in here a while because, you know, we didn’t have the ability, like we love streaming, we love whether it’s the Children’s Health Defense. I got rave reviews when I was out of pocket last weekend about you and just the folks down there. So what do you got for us? What happened yesterday?
CLAIRE DOOLEY (GUEST): Yeah. So, I mean, this is coming on the back of the Children’s Health Defense Conference last weekend where we saw this was kind of the movement of the grassroots.
STEVE BANNON (HOST): You were the movement of the grassroots. Yesterday was not grassroots. That wasn’t even grass tops.
CLAIRE DOOLEY (GUEST): We didn’t even talk about the difference between the energy in the room, right, the kind of folks that were in the room. So we’re going from Children’s Health Defense Conference this weekend to the MAHA Summit, which was put on by MAHA Action and a couple other different collaborators. This was where we’re really kind of watching the biotech industry have a seat at the table. And this is something that I think some people may have a problem with. But from my perspective, sitting in the room, talking with the people I talk to, the kind of world we want to build with MAHA is a world of science where we don’t silence people. We just win by having a better argument. So we allow these kinds of people into the room. It doesn’t mean that we have to agree with them. It just means that, you know, we can have a discussion. We can talk about the way to move forward. So we saw people like the CEO of CRISPR.
STEVE BANNON (HOST): Let me just pull back for a second. One of the reasons that, and correct me if I’m wrong because you’ve been doing this for a lot longer than I have, one of the reasons I think that Bobby Kennedy has become kind of an icon on the political right, people that are not with us on the other topics, and Nicole Shanahan, the food we eat, we have to totally rethink. Smart choices and what’s available in the soil, like in the agricultural part, better food, all of it. Putting it back on individuals but making sure you have total information, you know exactly what’s going on.
My concern about some of the biotech is that that’s like a hack sometimes. And just coming on, you know, Stephanie Ruhle. Excuse me, Stephanie Ruhle had this magnificent piece on the secret, and of course the Coinbase guy, Anderson, wanted to shock the world into acceptance by dropping the baby into the world.
So when you first think, you know, we had the CEO of CRISPR. She knows how to pull my chain. Just want to mention CRISPR, wanted to throw that one in there first. The basic principles are growing movement based upon people. You know, these big pharmaceuticals, big medical, they have a fair shot to actually live healthy and not have stuff forced on them. Or do you think it’s just the lobbyists telling them hey, if you don’t get into this movement now, this thing’s going to get so big and so powerful, you’re going to be dialed out?
CLAIRE DOOLEY (GUEST): Right. Absolutely. I think that they’re looking to have the grassroots actually saying so. Whenever it comes to yesterday, let’s talk about obviously I was bringing up CRISPR. They actually have a treatment for sickle cell disease. So I actually asked one of the parents who was there, who had a son who had been treated with this technology, and I said hey, I mean look, I get that they’re using it to treat sickle cell, but what about when it gets into hey, we’re going to have designer babies, we’re going to choose the eye colors. And he said, listen, I don’t care about that. What matters to me is that my son is healthy enough.
STEVE BANNON (HOST): So I think that’s part of how they always lead in, like the chip. Sickle cell. A couple of people about this designer baby on Stephanie Ruhle. And the first thing the guy said is well, look, what this effort in genetic engineering is first is to take care of some of the immediate problems we have like sickle cell. I mean, it was the very first example he used. Don’t they in a very smart way use that as kind of the, you know, by the way the parents that want to take care of this absolutely, they’re concerned.
CLAIRE DOOLEY (GUEST): You know, at birth, genetic engineering, genetic engineering. And we get into, you know, there were some topics covered yesterday about gene sequencing, and one of the panels, one of the experts quite literally said, we would love to sequence every person’s genome, run it through an AI, so that we can, this is something that.
STEVE BANNON (HOST): Was it a little quiet when he said that?
CLAIRE DOOLEY (GUEST): Right, exactly.
STEVE BANNON (HOST): I would love him to go to Children’s Health Defense down in Austin in front of those folks.
CLAIRE DOOLEY (GUEST): He’d probably get booed a good bit. But that’s the point of the MAHASummit, right. We’re giving industries a seat at the table. So the pharmaceutical company wanted to come and talk to us about making America healthy again. We would allow them to, but they’re not coming to the table. These are the kinds of folks who are coming to the table, and it doesn’t mean that we have. You’ve seen that, right. And so it’s just not about one election cycle, but something’s happening.
STEVE BANNON (HOST): Have you seen that? Because I do hear that there’s a lot of outreach to Bobby and that he’s working on certain things with the big pharma realizes this is just not going to go away, that you really have created a movement, right. And then the genome, the gene sequencing. Do you think that whether it’s the genetic engineering or big pharma, that they understand that you guys are fairly quasi permanent and they’ve got to take you and drive you in a certain direction?
CLAIRE DOOLEY (GUEST): They know that we’re not going away, but I don’t think they’re disillusioned that they can control us in any way or any means. And I think it’s mainly just about pharma. The current system is profiting off of sick people, whereas biotech is coming in and they’re saying, hey, we can profit off of making people healthier. It doesn’t mean they have to go along with it. It doesn’t mean that we have to opt in for these treatments. But I also think it’s important to have the conversation. At Maha, it’s about diet, lifestyle, and nutrition. But these are people who are talking more about preventive treatments, which could be a good alternative.
Follow Children’s Health Defense on X at @ChildrensHD
